Tag Archives: First

FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy

Print this page NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted approval of Elzonris (tagraxofusp-erzs; SL-401) for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)… Read More »

Samford alumnus introduces first telemedicine kiosk in an Alabama pharmacy – Yellowhammer News

As the owner of an independent pharmacy, Cole Sandlin’s goal is to make it a health care destination. “We’re located in a rural community, but I want my patients to have all of the amenities and services that bigger cities have to offer. This is what drives me to offer new things,” said Sandlin, a 2008 alumnus of Samford University’s… Read More »

The first time I felt I truly helped a patient

November 2017. I was on my pediatrics rotation at a local community clinic. My attending asked me if I could see Johnathan (identifying information and event details altered to protect confidentiality), an eight-year-old boy who has been increasingly fatigued since the start of the school year. I walked down the hallway laden with paintings of… Read More »